| Product Code: ETC036141 | Publication Date: Oct 2020 | Updated Date: Aug 2025 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Pharmacies and Drug Stores Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Pharmacies and Drug Stores Market Revenues & Volume, 2019 & 2026F |
3.3 United States (US) Pharmacies and Drug Stores Market - Industry Life Cycle |
3.4 United States (US) Pharmacies and Drug Stores Market - Porter's Five Forces |
3.5 United States (US) Pharmacies and Drug Stores Market Revenues & Volume Share, By Drug Type, 2019 & 2026F |
3.6 United States (US) Pharmacies and Drug Stores Market Revenues & Volume Share, By Type, 2021 & 2031F |
4 United States (US) Pharmacies and Drug Stores Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for healthcare services due to the aging population |
4.2.2 Rising prevalence of chronic diseases requiring ongoing medication |
4.2.3 Technological advancements in pharmacy services improving efficiency and customer experience |
4.3 Market Restraints |
4.3.1 Stringent regulations and compliance requirements in the pharmaceutical industry |
4.3.2 Pricing pressures from government healthcare programs impacting profit margins |
4.3.3 Competition from online pharmacies and retail chains |
5 United States (US) Pharmacies and Drug Stores Market Trends |
6 United States (US) Pharmacies and Drug Stores Market, By Types |
6.1 United States (US) Pharmacies and Drug Stores Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Pharmacies and Drug Stores Market Revenues & Volume, By Drug Type, 2016 - 2026F |
6.1.3 United States (US) Pharmacies and Drug Stores Market Revenues & Volume, By Prescription Drugs, 2016 - 2026F |
6.1.4 United States (US) Pharmacies and Drug Stores Market Revenues & Volume, By OTC Drugs, 2016 - 2026F |
6.2 United States (US) Pharmacies and Drug Stores Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Pharmacies and Drug Stores Market Revenues & Volume, By Community Pharmacy, 2016 - 2026F |
6.2.3 United States (US) Pharmacies and Drug Stores Market Revenues & Volume, By Hospital Pharmacy, 2016 - 2026F |
6.2.4 United States (US) Pharmacies and Drug Stores Market Revenues & Volume, By Clinical Pharmacy, 2016 - 2026F |
6.2.5 United States (US) Pharmacies and Drug Stores Market Revenues & Volume, By Industrial Pharmacy, 2016 - 2026F |
6.2.6 United States (US) Pharmacies and Drug Stores Market Revenues & Volume, By Compounding Pharmacy, 2016 - 2026F |
6.2.7 United States (US) Pharmacies and Drug Stores Market Revenues & Volume, By Consulting Pharmacy, 2016 - 2026F |
6.2.8 United States (US) Pharmacies and Drug Stores Market Revenues & Volume, By Others, 2016 - 2026F |
6.2.9 United States (US) Pharmacies and Drug Stores Market Revenues & Volume, By Others, 2016 - 2026F |
7 United States (US) Pharmacies and Drug Stores Market Import-Export Trade Statistics |
7.1 United States (US) Pharmacies and Drug Stores Market Export to Major Countries |
7.2 United States (US) Pharmacies and Drug Stores Market Imports from Major Countries |
8 United States (US) Pharmacies and Drug Stores Market Key Performance Indicators |
8.1 Percentage of revenue generated from value-added services (e.g., medication therapy management) |
8.2 Customer satisfaction scores related to service quality and convenience |
8.3 Percentage of prescriptions filled within a specified time frame |
8.4 Employee retention rate and satisfaction levels |
8.5 Adoption rate of digital health solutions and telepharmacy services |
9 United States (US) Pharmacies and Drug Stores Market - Opportunity Assessment |
9.1 United States (US) Pharmacies and Drug Stores Market Opportunity Assessment, By Drug Type, 2019 & 2026F |
9.2 United States (US) Pharmacies and Drug Stores Market Opportunity Assessment, By Type, 2019 & 2026F |
10 United States (US) Pharmacies and Drug Stores Market - Competitive Landscape |
10.1 United States (US) Pharmacies and Drug Stores Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Pharmacies and Drug Stores Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here